The document outlines the various types of routine monitoring visits in clinical research, particularly emphasizing the roles and responsibilities of Clinical Research Associates (CRAs) during these visits. It distinguishes between traditional monitoring, risk-based monitoring, and remote monitoring, highlighting the shift from traditional strategies to more targeted, efficient methods that consider site-specific risk profiles. Effective communication and preparation before, during, and after the monitoring visits are crucial for ensuring compliance and the overall success of clinical trials.
Related topics: